Pasireotide D7 TFA Salt
| Product Name | Pasireotide D7 TFA Salt |
|---|---|
| Alternate Names | Pasireotide Stable Isotopes, Stable Isotopes of Pasireotide |
| CAT No. | CS-O-15573 |
| CAS No. | 396091-75-1(Unlabeled) |
| Category | Stable Isotopes |
| Stock | IN-Stock |
| Mol. Wt. | 396091-73-9 (Unlabeled) g/mol |
| Mol. For. | C64H62D7F9N10O15 |
| Hazardous | This is not a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Pasireotide |
| Therapeutic | Synthetic Peptides |
| Smileys | FC(F)(F)C(O)=O.O=C([C@](NC([C@@H](NC([C@@H](NC1=O)CCCCN)=O)CC2=CC=C(OC([2H])([2H])C3=C([2H])C([2H])=C([2H])C([2H])=C3[2H])C=C2)=O)([H])CC4=CC=CC=C4)N5[C@@](C(N[C@@H](C6=CC=CC=C6)C(N[C@]1([H])CC7=CNC8=CC=CC=C78)=O)=O)([H])C[C@@H](OC(NCCN)=O)C5 |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Pasireotide D7 TFA Salt is a synthetic peptide analog of somatostatin, a naturally occurring hormone that regulates the secretion of various hormones in the body. Pasireotide D7 TFA Salt is used to treat patients with Cushing's disease, a rare condition caused by a tumor in the pituitary gland that produces excessive amounts of adrenocorticotropic hormone (ACTH). This leads to the overproduction of cortisol, a steroid hormone that can cause a range of health problems, including weight gain, high blood pressure, and diabetes.
Pasireotide D7 TFA Salt works by binding to specific receptors in the pituitary gland and blocking the production of ACTH. This, in turn, reduces the production of cortisol in the body and helps alleviate the symptoms of Cushing's disease. Pasireotide D7 TFA Salt is administered as an injection into the muscle or under the skin, and the dosage is determined by the patient's weight and medical history.
Chemically, Pasireotide D7 TFA Salt is a deuterated form of pasireotide, which means that it contains seven deuterium atoms instead of seven hydrogen atoms. This modification does not change the mechanism of action of the drug, but it can improve its stability and reduce the risk of side effects. Pasireotide D7 TFA Salt is a white to off-white powder that is soluble in water and other polar solvents. It is typically supplied as a sterile lyophilized powder that is reconstituted with a diluent before administration.
Get an Instant Quote
Related Compounds
Pasireotide-d5 | Pasireotide-d7 |